ACE and Duchenne muscular dystrophy: We also found few estimates pertaining to specific features of pharmacological cardiac intervention, such as the comparative effect of different doses or regimens, but one study examined the impact of the timing of initiation of ACE inhibitors in patients with DMD or BMD, reporting of a significant effect only among those treated at LVEF < 55% [14].